Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

The post is based on the assumption RLF-100 gets approved for COVID-19/ARDS?? What will be the FDA pathway to repurpose RLF-100? Is the pathway 505(b)(2)? If yes, will it be faster than the current fast tracked IND?? Will COPD and Asthma be next?? Will RFL-100 be the next standard of care for several indications??

QUOTE: The thing to remember is the market for this may be much larger than COVID. If it works as well as it appears it could become the standard of care for anyone with an ARDS like disease, from any cause. That’s a lot of lives saved. ~BSfreeMD

I thought it would be better than politics